Explores motor neuron diseases, discussing their classification, pathological signatures, etiology, and potential treatments, with a focus on Spinal Muscular Atrophy.
Explores protein aggregation control through optimal strategies, inhibitors, and spatial regulation using liquid compartments, shedding light on drug interventions and aggregate dynamics.
Delves into the contrasting effects of chaperones on amyloid beta peptide aggregation, exploring inhibitors, oligomer quantification, and antibody impacts.
